Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,992.28
(
1.03%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
100.23
(
1.96%
)
Bitcoin
75,836.03
(
1.33%
)
News Focus
News Focus
Post# of 257250
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 92535

Monday, 04/19/2010 6:23:57 PM

Monday, April 19, 2010 6:23:57 PM

Post# of 257250
BMY Presents Phase-2a Data on NS5A Inhibitor at EASL

http://www.bms.com/research/investigational/hepatitis/Pages/BMS790052_easl.aspx

BMY did not issue a PR for this BMS-790052 presentation, but the info was posted on BMY’s new webpage for real-time pipeline updates (#msg-49176165). Due to the formatting, this info is difficult to post and is best read by chasing the link above (it will not expire :- )).

The abstract for this study was posted in #msg-47876219; an updated version of the abstract with a data table is at http://www.kenes.com/easl2010/Orals/297.htm .


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now